Loading...
Cardlytics reported a decrease in total revenue for Q4 2022, with a net loss attributable to common stockholders. However, the company saw an increase in MAUs and Bridg ARR.
Total revenue decreased by 8.4% to $82.5 million compared to Q4 2021.
Net loss attributable to common stockholders was $(378.3) million, or $(11.32) per diluted share.
Non-GAAP net loss was $(9.7) million, or $(0.29) per diluted share.
Cardlytics MAUs increased by 4.2% to 182.7 million compared to Q4 2021.
Cardlytics anticipates billings, revenue, and adjusted contribution to be in the following ranges for Q1 2023.